Efficacy of SXN in the Treatment of Iron Deficiency Anemia: A Phase IV Clinical Trial

Figure 2

Effects of SXN on the peripheral hemogram in IDA patients. HGB increased after 1 month of SXN treatment in the adult group (a) and the child group (b). The reticulocyte counts increased at the end of treatment in the M-SXN and H-SXN adult groups (c) and in the M-SXN child group (d). P < 0.05. P < 0.01, compared with pretreatment.

(a)

(b)

(c)

(d)